MedPath

PRO-LORAZEPAM

PRO-LORAZEPAM

Approved
DIN Number

00655651

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

PRO DOC LIMITEE

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00655651
AIG Number0110731001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LORAZEPAMActive
Strength: 1 MG
Monograph: LORAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.